Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin for postpartum depressive emotion
ChiCTR2000038419Phase 4Recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxytocin in postpartum depression (PPD) (3 arms), sponsored by Second Hospital of Shandong University. Primary endpoints: Edinburgh Postnatal Depression Scale and VAS numerical rating scale. Started Sep 2020; status: recruiting.
02
Drugs
oxytocin
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2000038419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038419.